Harm Intensification

RSS Feed for this category

Four Ways Fentanyl Could Radically Disrupt the Global Drug Trade

The synthetic opioid fentanyl isn't just killing American drug users by the thousands. Its emergence also signals a shift in the decades-old contours of the global drug trade, with ramifications not only for traditional drug-producing countries and drug trafficking networks but also for US foreign policy.

Black market fentanyl is not just wreaking havoc on the streets of American cities. (Creative Commons)
Synthesized from chemicals -- not from papaver somniferum, the opium poppy -- fentanyl is about 50 times stronger than heroin and is severely implicated in the country's drug overdose crisis, accounting for almost 20,000 deaths in 2016.

Illicit fentanyl is typically mixed with other opiates, such as heroin, resulting in much stronger doses of opioids than users expect, thus leading to opioid overdoses. But it is also increasingly also showing up in non-opiate drugs, resulting in fentanyl overdose deaths among unsuspecting methamphetamine and cocaine users.

But the havoc super-potent fentanyl is wreaking among drug users pales in comparison with the dramatic changes it could prompt in the global illicit drug production industry. As academic researchers Vanda Felbab-Brown, Jonathan Caulkins, and Keith Humphreys write in the current issue of Foreign Affairs, fentanyl's rise has the potential to cause disruption and innovation in black markets.

Here are four ways fentanyl alters the illegal drug production and distribution status quo:

1. It doesn't require an agricultural base. Virtually all of the other opioids on the black market, from heroin to morphine, oxycodone, and hydrocodone, require land to grow poppies on. And they require land that is outside cdthe effective control of the state. Non-state actors who can control such areas, whether it's the Taliban in Afghanistan or the drug cartels in southern and western Mexico, reap the profits and power of that control. With the ascent of lab-produced fentanyl made out of chemicals, traditional opiate producers should see their profits and their influence undermined.

2. It doesn't require a large workforce. Traditional opium production requires a large seasonal workforce of people to plant and tend the poppies, score the pods and scrape off the leaking opium, and then process and package the raw opium. Other workers will get jobs processing raw opium into heroin. All of those jobs bring money into the hands of poor agricultural families and political capital to the traffickers, whether it's the Taliban in Afghanistan or the cartels in Mexico. With fewer job opportunities to offer up, the traffickers lose clout.

3. It doesn't require an elaborate smuggling infrastructure. Because fentanyl is so potent, small amounts of the drug can contain huge numbers of doses, and that means it doesn't require transportation networks of trucks, planes, and boats to get an agricultural crop from the valleys of Afghanistan or the mountains of Mexico to consumers in the US Fentanyl is so potent, medicinal doses are measured in micrograms, and packages of it worth hundreds of thousands of dollars can fit inside a Priority Mail envelope. With smuggling fentanyl as easy as dropping a package in the mail, international drug smuggling organizations now have competition they never had before.

4. All of this can change the dynamics of US foreign policy. If plant-based opiates lose market share to synthetics in the future, this can weaken both insurgencies (Afghanistan) and criminal networks (Mexico). Ever since the US invasion of Afghanistan in 2001, drug warriors have been constrained in their efforts to go after the Afghan opium crops because of fears it would drive poppy-dependent peasants into the hands of the Taliban. If opium production becomes relatively less important vis-à-vis fentanyl production, that constraint on an aggressive US response to Afghan opium production is weakened. Similarly, in Mexico, to the degree that fentanyl displaces peasants and processors and weakens the link between drug cartels and rural populations, it increases the ability of the Mexican government and its American backers to crack down even harder on the cartels.

Under drug prohibition, there is a strong impetus to come up with more pure, more potent, and more compact products. Fentanyl is the ultimate expression of that imperative, and its arrival is changing the contours of the global drug industry. Who knows how it will play out?

Chronicle AM: House Dems Want Action on Naloxone Pricing, German Decrim Hint, More... (5/21/18)

There's too much marijuana in Oregon, Utah medical marijuana foes try another tack to block the initiative, Africa gets its first medical marijuana dispensary, and more.

Price gouging on the opioid overdose reversal drug needs to stop, Democratic House members say. (PA Health Department)
Marijuana Policy

Oregon US Attorney Warns of "Significant Overproduction" of Legal Marijuana, Will Target Diversion. US Attorney Billy Williams said last Friday that the state has a "significant overproduction" problem and that he would prioritize enforcement of overproduction, diversion to other states, and organized crime. The state currently has nearly a million pounds of marijuana buds in inventory, and it's estimated that Oregon's billion dollar a year industry includes about $300 million worth of pot to diverted to the black market.

Pennsylvania State Senator Calls on DAs to Quit Prosecuting Small-Time Pot Cases. One of the Keystone State's leading voices for marijuana law reform, state Sen. Daylin Leach (D), last Friday published an open letter to the state's district attorneys urging them to quit prosecuting pot possession and smoking cases. Leach cited the nine states that have already legalized marijuana and warned, "If people are convicted this year, and legalization occurs next year or the year thereafter, thousands of people will have a stain on their record that will be extremely difficult or impossible to remove."

Medical Marijuana

Utah Medical Marijuana Foes Sue to Block Initiative from Going to Voters. Drug Safe Utah, a group formed to oppose the medical marijuana initiative, went to court last Thursday to try to block it. In court filings, the group argued that the lieutenant governor, whose office oversees elections, doesn't have the authority to allow campaigners to gather signatures. Drug Safe Utah argued that state officials couldn't act on the initiative because it "conflicts with federal law."

Harm Reduction

House Democrats Call on Trump Administration to Lower Naloxone Price. A group of House Democrats led by Reps. Lloyd Doggett (D-TX) and Peter Welch (D-VT) have sent a letter to White House Kellyanne Conway asking for executive action to curb rising prices for naloxone, the opioid overdose reversal drug. "Federal agencies have the authority to use patented inventions… when in the interest of the public good," the lawmakers wrote. "The current opioid crisis requires invoking this provision."

International

German Drug Official Hints at Move Toward Marijuana Decriminalization. In a report released last week, German drug commissioner Marlene Mortler appeared to call for marijuana decriminalization. "Anyone caught by the police in the future for possession of cannabis for personal consumption should be allowed to choose whether to pay a fine or voluntarily seek help from the expert," she said. German drug arrests were up more than 6% last year, while marijuana arrests were up 14%. About 80% of all marijuana cases were for simple possession.

Africa Gets First Medical Marijuana Dispensary. A medical marijuana dispensary has opened in Durban, South Africa, making it the first on the continent. The store is currently only selling products without THC. "We want to break the stigma on cannabis, to showcase that cannabis can be used effectively to treat a number of conditions and to integrate medical professionals as well as traditional healers to allow the whole of South Africa a holistic approach to health care," said dispensary spokesperson Kirithi Thaver.

Chronicle AM: 2019 Ohio Init Gears Up, Fed Treatment Bill Advances, More... (5/19/18)

Michigan legalization initiative foes urge the legislature to legalize it, an Ohio legalization initiative can begin signature gathering, a federal drug treatment bill exclusively targeting opioids advances, and more.

Marijuana Policy

Michigan Legalization Initiative Foes Urge Legislature to Pass Legalization. In a surprise move, a campaign committee formed to oppose the pending marijuana legalization initiative is now asking the legislature to preemptively pass legalization. Keep Pot Out of Neighborhoods and Schools issued a press release Thursday calling on the legislature to approve the initiative. Under state law, the legislature can just pass the initiative, or, if it rejects it or fails to act, the initiative would go before voters in November. State Republicans worry that interest in the initiative will drive turnout at the polls, worsening their chances in the election.

Ohio Legalization Initiative Cleared for Signature Gathering. The state Ballot Board on Thursday cleared a legalization initiative, the Marijuana Rights and Regulation Act, for signature gathering. Campaigners need to come up with some 305,000 valid voter signatures to qualify for the initiative. The deadline to make the November ballot is in July, but campaigners say there are instead aiming at 2019.

Medical Marijuana

House Panel Approves Medical Marijuana Protections. The House Appropriations Committee on Thursday approved an amendment from Rep. David Joyce (R-OH) to continue to protect state-legal medical marijuana programs from federal interference. The amendment is now part of the House's Commerce, Justice and Science appropriations bill. The amendment, previously known as the Rohrabacher-Blumenauer amendment, bars the expenditure of federal funds to go after state-legal medical marijuana.

Illinois Legislature Approves Medical Marijuana in Schools. The Senate on Thursday approved a bill that would allow for the use of medical marijuana in elementary and middle schools. The bill has already passed the House and now goes to the desk of Gov. Bruce Rauner (R). The bill would let parents administer marijuana-infused products, but not smoked marijuana, to their child on school grounds.

Missouri Medical Marijuana Bill Dies. A medical marijuana bill, House Bill 1554, has died in conference committee, leaving the path open for at least one medical marijuana initiative to go before the voters in November. The bill came as an amendment to a healthcare bill and would only have allowed patients with terminal illnesses to use non-smokable marijuana.

Heroin and Prescription Opioids

House Panel Advances Bill to Expand Drug Treatment, But Only for Opioids. The House Committee on Energy and Commerce on Thursday advanced a bill that would free up Medicaid dollars for spending on treatment for opioid addictions, but some lawmakers warned that the country is facing a polydrug crisis. "I'm troubled that this bill would expand treatment only to people with opioid use disorder as opposed to those with other substance use disorders like alcohol, crack-cocaine, methamphetamine," said Rep. Jan Schakowsky (D-IL). "This bill is not only blind to the reality faced by people suffering from substance use disorder but it's also discriminatory." The measure is HR 5797.

One of the World's Most Prestigious Medical Journals Just Called for Legalizing All Drugs

Embracing a harm reduction and public health perspective, one of the world's most prestigious medical journals has released a signed editorial calling for the legalization, taxation, and regulation of currently illegal drugs.

In a editorial last Thursday entitled Drugs Should Be Legalised, Regulated, and Taxed, Fiona Godlee, editor in chief of the British Medical Journal, notes that under drug prohibition, the global trade "fuels organized crime and human misery," and asks, "Why should it not instead fund public services?"

Citing an opinion piece in the same issue of the BMJ from British members of the Law Enforcement Action Partnership (LEAP, formerly known as Law Enforcement Against Prohibition) Jason Reed and Paul Whitehouse, Godlee notes that in the United Kingdom (as in the United States) "vast sums are spent prosecuting individuals and trying vainly to interrupt the flow of drugs into cities" while that money would be much better "spent on quality control, education, treatment for drug users, and child protection." Under legalization, "revenues could be diverted from criminal gangs into government coffers," she writes.

Godlee notes that the global drug prohibition consensus is fraying around the edges, and points to the example of Portugal, which decriminalized the possession of all drugs in 2001. There, drug use remains in line with levels in other European countries, but the harms associated with drug use under prohibition have decreased dramatically, particularly in terms of fatal drug overdoses and the spread of injection drug-related infectious disease.

Godlee also pointed to the Netherlands, the United States, and soon, Canada, where "regulated markets for the sale of cannabis generate substantial tax revenues."

Again returning to the opinion piece by Reed and Whitehouse, Godlee writes that "when law enforcement officers call for drugs to be legalized, we have to listen." Ditto for when doctors speak up, she adds, noting that just last month, the Royal College of Physicians came out in favor of drug decriminalization, joining the British Medical Association, the Faculty of Public Health, and the Royal Society of Public Health in supporting drug policy reform.

"This is not about whether you think drugs are good or bad," Godlee concludes. "It is an evidence based position entirely in line with the public health approach to violent crime… The BMJ is firmly behind efforts to legalize, regulate, and tax the sale of drugs for recreational and medicinal use. This is an issue on which doctors can and should make their voices heard."

Unfortunately for the BMJ and the other public health advocates, as in the United States, the political class in the United Kingdom isn't yet on board with evidence-based best practices on drug policy. But this editorial loosens another brick in the wall -- on both sides of the Atlantic.

Chronicle AM: McConnell Just Says No to Legal Weed, Walmart Tightens Prescribing, More... (5/9/18)

Mitch McConnell just says no, a House committee advances a VA medical marijuana bill, Pennsylvania's governor and attorney general aren't down with a Philadelphia safe injection site, and more.

Mitch McConnell is down with hemp, but not pot. (Flickr/Gage Skidmore)
Marijuana Policy

Mitch McConnell Confirms GOP Still the Party of "No" on Legal Marijuana. Senate Majority Leader Mitch McConnell (R-KY) said he was not interested in legalizing marijuana, even though his Democratic counterpart, Minority Leader Chuck Schumer (D-NY) has endorsed it. "I do not have any plans to endorse legalization of marijuana," McConnell said. McConnell is pushing for the legalization of hemp, though: "These are two entirely separate plants," McConnell said. "I hope everybody understands that. It is a different plant. It has an illicit cousin which I choose not to embrace."

Medical Marijuana

House Committee Advances Veterans Affairs Medical Marijuana Research Bill. The House Veterans' Affairs Committee Tuesday unanimously approved a measure that aims to increase VA research on medical marijuana. The bill would specify that the agency has the ability to research the herb for conditions including PTSD. The measure is part of a package of bills lawmakers hope to pass this month.

Missouri Senate Gives Initial Approval to Medical Marijuana Bill. The Senate Tuesday gave initial approval to House Bill 1554, which would allow people suffering from specified serious illnesses to use non-smokeable medical marijuana. The bill has already passed the House and now goes to the Senate Committee on Health and Pensions for a second reading. If it survives that, it then goes to the full Senate for a floor vote.

Utah "Right To Try" CBD Medical Marijuana Law Now in Effect. A limited medical marijuana law is now in effect. Under House Bill 195, which passed in March, terminally ill patients will be able to access CBD cannabis oil under a provision that expands the state's 2015 Right to Try Act. Also now in effect is House Bill 197, which establishes a medical marijuana cultivation program in the state. Both of these laws could soon be irrelevant, though: A much broader medical marijuana initiative will be on the ballot in November.

Heroin and Prescription Opioids

Study: Prescription Drug Monitoring Programs Have Little Effect on Overdose Deaths. A new study from Columbia University's Mailman School of Public Health finds that prescription drug monitoring programs may be only "marginally effective" in reducing drug overdose deaths. "What it really offers is this cautionary tale that says a few things. One, the amount of money and resources that are going into these programs need to be evaluated to understand what their ultimate costs are," social epidemiologist David Fink said. "Studies have come out in the past looking at reduced prescribing behavior, but we're taking it to the next level -- looking at fatal or nonfatal overdoses. And what we're seeing is that when you actually look at the literature, it isn't that strong to support" the programs. The study also found that half the studies looking at heroin overdose rates found a significant increase after prescription drug monitoring programs were implemented.

Walmart Tightens Opioid Prescription Policies. The nation's largest pharmacy chain announced Monday that beginning within 60 days, it will only fill first-time acute opioid prescriptions for a week or less nationwide. It will also limit dosages to 50 morphine milligram units per day. Walmart didn't say what it would do about patients who require greater dosages than that.

Harm Reduction

Officials in Philadelphia want a safe injection site in a bid to reduce drug overdoses that killed more than 1,200 people in the city last year, but the Democratic governor and attorney general aren't on board. A spokesman for Gov. Tom Wolf said the idea "presents a number of serious public health and legal concerns, while a spokesman for Attorney General Josh Shapiro said changes in federal law would have to come before he could support a safe injection site.

NYC Mayor de Blasio Endorses Safe Injection Site Plan

Just a day after close to a hundred community activists, reform advocates, and local elected officials took to the streets outside New York City's City Hall Wednesday to demand that Mayor Bill de Blasio (D) move on a long-delayed feasibility study on safe injection sites, the mayor has moved -- and further than they expected.

New York City Mayor Bill de Blasio comes out for safe injection sites. (Flickr)
On Thursday evening, the mayor's office announced de Blasio's support for a plan to open four of the sites, which the office refers to as Overdose Prevention Centers, a year from now, after a period of consultation with stakeholders.

"After a rigorous review of similar efforts across the world, and after careful consideration of public health and safety expert views, we believe overdose prevention centers will save lives and get more New Yorkers into the treatment they need to beat this deadly addiction," de Blasio said in a statement.

Safe injection sites (SISs) -- or safe injection facilities or supervised injection facilities or supervised consumption sites or overdose prevention centers -- allow drug users to inject (or sometimes inhale) their own drugs under medical supervision. They typically also have a social services component that aims to assist drug users in finding drug treatment and other services.

Operating in around 90 cities in Europe, Australia, and Canada, they are a proven harm reduction intervention. Numerous peer-reviewed scientific studies have shown they reduce public disorder; increase access to treatment, reduce the risk of HIV, Hep C, and bacterial infections; reduce drug overdose deaths; and reduce medical costs thanks to a reduction in disease and overdose, while at the same time increasing access to cost-saving preventive healthcare. What SISs don't do, the studies have found, is increase crime, injection drug use, or the initiation of new drug users.

Yet no such sites operate in the United States. Pushes are underway in several cities, including Philadelphia, San Francisco, and Seattle, but all have faced challenges ranging from moralism and NIMBYism to the fact that they would appear to violate federal law. Just this week, DEA spokesman Melvin Patterson said they violate the Controlled Substances Act and are "subject to being prosecuted." Given the proclivities of the Trump administration, that is probably not a threat to be taken lightly.

Still, the cities are willing to push on the issue, the American Medical Association has endorsed the notion, and legislatures in a number of states are pondering bills to allow them. And now, with the country's largest city coming on board, momentum for the sites is only growing stronger.

In New York City, where the SIF NYC Campaign, a coalition of dozens of community, drug reform, public health, medical, and religious groups has been pressuring the administration to act for months, the mayor's announcement was greeted with relief.

"Mayor de Blasio's embrace of safer consumption spaces is a critical step forward in preventing overdose deaths in New York City. We know that safer consumption spaces are an evidence-based solution that can help dramatically in saving lives, reducing criminalization, and improving public health," said Kassandra Frederique, New York state director at the Drug Policy Alliance. "New York can and must be a leader now in saving lives by opening safer consumption spaces swiftly."

That will take some political acumen in dealing with city district attorneys and the state Health Department, which answers to Gov. Andrew Cuomo, with whom de Blasio's relations are strained at best. It will also take some political fortitude in taking on the Sessions Justice Department and the DEA.

De Blasio's announcement marks the successful culmination of the campaign to bring the city on board with safe injection sites as a harm reduction and overdose prevention measure, but it's just the beginning of the fight to actually get them up and running.

Chronicle AM: Feinstein Comes Around on Legalization, Synthetic Opioids Fuel ODs, More... (5/2/18)

Maine's legislature overrides a veto to pass a bill implementing legal marijuana sales, California's senior senator finally comes on board with legalization, Canada's legalization push faces some hiccups, and more.

Dianne Feinstein. California's senior senator finally hops on the marijuana train. (Wikimedia Commons)
Marijuana Policy

Dianne Feinstein Drops Opposition to Legal Marijuana. California's senior US senator, Democrat Dianne Feinstein, a longtime foe of marijuana legalization, has seen the light. In an interview Tuesday with McClatchy, she said she was now open to considering federal protection for state-legal marijuana. "Federal law enforcement agents should not arrest Californians who are adhering to California law," said Feinstein, who is facing a primary challenge from Kevin de Leon, who supports marijuana legalization.

Maine Legislature Overrides Governor's Veto of Marijuana Legalization Implementation Bill. Both the House and Senate voted Wednesday to override Gov. Paul LePage's (R) veto of LD 1719, the bill designed to allow the state's legal marijuana industry to get up and running. The bill would establish a system of licensed retail marijuana outlets to sell marijuana to adults. Recreational marijuana sales would be taxed at 20%, while medical marijuana patients would continue to pay a 5.5% tax.

Heroin and Prescription Opioids

Synthetic Opioids Fueling Rise in Overdose Deaths. Synthetic opioids such as fentanyl are now the most common drug involved in fatal drug overdoses, researchers from the Substance Abuse and Mental Health Services Administration (SAMHSA) reported Tuesday. Fatal overdoses involving synthetic opioids accounted for 14% of all overdose death in 2010, but 46% in 2016. Of more than 42,000 opioid-related overdose deaths, synthetics were implicated in more than 19,000, prescription opioids in more than 17,000, and heroin in more than 15,000. The numbers add up to more than 42,000 because many ODs involve multiple drugs.

Drug Testing

Trucking Industry Wants Hair Testing for Drivers. The Alliance for Driver Safety & Security, also known as the Trucking Alliance, has announced it will push for a new federal drug testing law to undergo drug testing to prove they have been free of opioids or other illegal drugs for at least 30 days. That means testing hair follicles, which allows drug use dating back weeks or months to be spotted. The industry complains that urinalysis drug testing isn't catching enough opioid addicts or "lifestyle" drug users.

International

Canada Prime Minister Leaves Door Open for Possible Legalization Delay. Faced with calls from two Senate committees to delay the marijuana legalization bill, Prime Minister Justin Trudeau left the door open for a possible slowdown in enacting the government's marijuana legalization bill. The Senate aboriginal peoples committee has called for a one-year delay for broader consultations with indigenous communities, and a separate committee has called for a delay to clarify what will happen to Canadians trying to enter the US. Trudeau didn't reply directly when asked about a possible delay, but said, "We'll continue to consult a broad range of Canadians, and as our parliamentary secretary Bill Blair says regularly, legalization is not an event, it's a process. And that process will continue," he said.

Colombia Coca Eradication Falls Far Short of Goal. The government will successfully eradicate only about 60% of the coca plantings it pledged to eradicate last year, President Juan Manuel Santos said Tuesday. And it will take longer than the government first announced. Colombia had vowed to eradicate 125,000 acres of coca planting by the end of last year, but Santos said it would only eradicate about 75,000 acres, and that would be by the of this month.

(This article was prepared by StoptheDrugWar.org's 501(c)(4) lobbying nonprofit, the Drug Reform Coordination Network, which also pays the cost of maintaining this web site. DRCNet Foundation takes no positions on candidates for public office, in compliance with section 501(c)(3) of the Internal Revenue Code, and does not pay for reporting that could be interpreted or misinterpreted as doing so.)

Chronicle AM:Mitch McConnell Files Hemp Bill, Mexico Minister Says Legalize It, More... (4/13/18)

A pair of senators demand that Jeff Sessions quit blocking marijuana research, Mitch McConnell files a federal hemp bill, Mexico's tourism minister says his country should allow states to legalize weed, and more.

Senate Majority Leader Mitch McConnell files a bill to allow for domestic hemp cultivation. (Flickr/Gage Skidmore)
Medical Marijuana

Bipartisan Pair of Senators Call on Sessions to Stop Blocking Marijuana Research. Sens. Kamala Harris (D-CA) and Orrin Hatch (R-UT) sent a letter Thursday to Attorney General Jeff Sessions to demand that he stop blocking efforts to ramp up research on marijuana's medical benefits. "The benefits of research are unquestionable," Sens. Orrin Hatch (R-UT) and Kamala Harris (D-CA) wrote, taking Sessions to task for blocking applications for new research grows. "Nineteen months have elapsed since the DEA announced its request for expanded marijuana research," they noted, demanding that Sessions respond by May 15 about the status of the research application reviews.

Louisiana House Approves Expansion of Medical Marijuana Program. The House on Thursday approved House Bill 579, which expands the list of qualifying conditions to include Parkinson's Disease, chronic pain, severe muscle spasms, and PTSD. That means the number of qualifying conditions would rise from 10 to 14. The bill now goes to the Senate.

Hemp

Mitch McConnell Files Federal Hemp Bill. Senate Majority Leader Mitch McConnell (R-KY) has filed Senate Bill 2667, which aims to allow for domestic hemp production by removing non-psychoactive marijuana varieties known as hemp from the Controlled Substance Act. Cosponsoring the bill are Sens. Ron Wyden (D-OR) and Jeff Merkley (D-OR). Companion legislation in the House was filed by McConnell's home state homeboy Rep. Jim Comer (R-KY).

Heroin and Prescription Opioids

Making Opioids Tougher to Abuse Led to Spike in Heroin Deaths, Study Finds. A new working paper from the National Bureau of Economic Research finds that a 2010 effort to deter opioid abuse led to a jump in heroin overdoses. The paper studied what happened after OxyContin was reformulated to be more abuse-resistant and found that "each prevented opioid death was replaced with a heroin death."

Law Enforcement

DEA Gouged Taxpayers, Benefited Ex-Employees, Audit Finds. A report from the Justice Department's Office of the Inspector General has found that the DEA's Asset Forfeiture Program farmed out contracts to recently retired former employees, paying them more than half a million dollars more than they would have been paid if they had remained at the agency. The former employees worked for a private contractor called Maximus Inc., which was paid $85 million between 2013 and 2017 to handle asset forfeiture cases. Many of the ex-employees went to the same offices they had worked at as DEA employees, and former DEA employees accounted for 40% of Maximus's asset forfeiture workforce.

International

Mexico Tourism Minister Says Country Should Let States Begin to Legalize Weed. Tourism Minister Enrique de la Madrid said Wednesday that Mexico should allow states to begin legalizing marijuana, in part to address record cartel violence. "I think in Mexico we should move towards regulating it at state level," he said, calling it "illogical" to divert funds from fighting kidnapping, rape and murder to arrest people using marijuana.

Chronicle AM: Decrim Vote in Albuquerque, Bad "Fake Weed" in Illinois, More... (4/3/18)

A legalization bill fails in Arizona, another one sputters in Connecticut, a bad batch of synthetic cannabinoids is wreaking havoc in Illinois, and more.

Apparently contaminated synthetic cannabinoids in Illinois have left two dead, dozens injured. (Wikimedia)
Marijuana Policy

Arizona Legalization Fails Dies in Statehouse. There will be no legalization via the legislature in Phoenix this year after lawmakers refused to act on a measure that would have put the issue before the voters. HCR 2037 had been assigned to three different committees, but never got any action in any of them. Sponsors Reps. Todd Clodfelter (R-Phoenix) and Mark Cardenas (D-Phoenix) vow to try again next year.

Connecticut Legalization Bill Gets Committee Hearing. The House Finance, Revenue and Bonding Committee held a hearing on a legalization bill, House Bill 5582, on Monday, making it the fourth committee to hold a hearing on marijuana legalization this session. But the bill is unlikely to pass this year since one committee has already rejected it and another will not be voting on whether to advance it. At the hearing, the Office of Fiscal Analysis reported that the state could expect tax revenues from pot at between $30 million and $63 million, depending on the tax model used.

Albuquerque City Council Votes to Decriminalize Marijuana Possession. City council members voted Monday night on a party line vote to decriminalize the possession of up to an ounce of marijuana. Offenders would be hit with a $25 fine on a first offense. A similar measure passed in 2015, only to be vetoed by the mayor. But now there's a new mayor, so stay tuned.

New Psychoactive Substances

Illinois Sees Bad Synthetic Cannabinoids Kill Two, Leave Dozens Bleeding. Synthetic cannabinoids apparently cut with rat poison have killed two people in Illinois and left 56 others experiencing severe bleeding. The bad dope has shown up in Chicago and the central part of the state, the Department of Public Health said Monday.

Asset Forfeiture

Kansas Governor Signs Minor Asset Forfeiture Reform Bill. Gov. Jeff Colyer (R) has signed into law House Bill 2459, which would make small reforms in the state's civil asset forfeiture law. Under the bill, police who seize property will have to report on what they took and how they used the seized property.

Chronicle AM: NJ Gov Says Legalize It This Year, Duterte Pulls Out of ICC, More... (3/14/18)

New Jersey pot legalization politics heats up, the CDC reports a big jump in opioid overdoses, the Sentencing Commission ponders increasing fentanyl penalties, Duterte pulls the Philippines out of the International Criminal Court, and more. 

New Jersey Gov. Phil Murphy (D) says legalize it this year. (Wikimedia)
Marijuana Policy

New Jersey Legalization Bill Filed. Assemblyman Reed Gusciora (D-Mercer) has filed Assembly Bill 3581, which would legalize the possession of marijuana, allow for home cultivation, and set up a system of taxed and regulated marijuana commerce. The bill envisions some 400 pot shops across the states.

New Jersey Governor Budgets for Legal Weed, Wants It This Year. Gov. Phil Murphy (D) wants the legislature to legalize marijuana this year and has included $60 million in tax revenues from legal weed in his state budget proposal. "I am committed to working with you to get this passed this year," Murphy said in his budget address at the Statehouse in Trenton.

<iframe width="533" height="300" src="https://www.youtube.com/embed/T2fQkOAd694" frameborder="0" allow="autoplay; encrypted-media" allowfullscreen></iframe>

Medical Marijuana

Arkansas Sued Over Denial of Cultivation License. A would-be medical marijuana provider who failed to win a license from the state has sued the Medical Marijuana Commission. Natural Health filed suit Thursday in Pulaski County Circuit Court charging the selection process was "plagued by unlawful and inconsistent procedures" and that members of the commission were biased or had conflicts of interest. . 

Heroin and Prescription Opioids

CDC Reports Opioid Overdoses Jumped 30% in 14 Months. Opioid overdoses in the US increased by about 30% over the course of 14 months, according to a report issued Thursday by the Centers for Disease Control and Prevention (CDC). Data collected in 16 states across the country show some emergency rooms experienced as high as a 109% increase (Wisconsin) in overdoses between July 2016 and September 2017 while others — including Massachusetts, New Hampshire and Rhode Island — reported declines. "This fast-moving epidemic affects both men and women, and people of every age. It does not respect state or county lines and is still increasing in every region in the United States," said CDC Acting Director Anne Schuchat.

Sentencing

US Sentencing Commission Ponders Increased Penalties for Fentanyl Dealers. The Sentencing Commission is holding a hearing today on whether to lengthen prison sentences for people caught dealing fentanyl. Under the proposal, first-time offenders caught selling a half ounce of fentanyl would face up to five years in prison—more than twice the current sentence. While the Justice Department supports the proposal, the Drug Policy Alliance says that implementing the plan would have "perverse public health impacts."

International

Experts at UN Side Event Call for Access to Morphine for Severe Pain. The Organization for the Prevention of Intense Suffering (OPIS), a Swiss think-and-do tank, and International Doctors for Healthier Drug Policies (IDHDP), a London-based network, are holding a side event with expert panelists during the 37th session of the UN Human Rights Council, titled "Ending the Agony: Access to Morphine as an Ethical and Human Rights Imperative." The groups are calling for a centralized strategy for access to opioid pain relievers, better balance between access and control, "an ambitious scale-up of training and oral morphine distribution," and destigmatizing the use of morphine and other opiates.

Duterte Will Withdraw Philippines from International Criminal Court. In a statement Wednesday, President Rodrigo Duterte announced that the Philippines will withdraw from the ICC. The move comes weeks after the ICC announced it was investigating allegations the Duterte government committed crimes against humanity in its bloody war on drugs, which has left thousands dead since he took office in May 2016.

Panamá Opens the Door to CBD Medicinal Marijuana with a Proposed Law. The government has filed a bill to allow the use of CBD cannabis oil, Bill 595. It was prompted out of concern for children suffering from epilepsy. The bill could be amended by the National Assembly.

Drug War Issues

Criminal JusticeAsset Forfeiture, Collateral Sanctions (College Aid, Drug Taxes, Housing, Welfare), Court Rulings, Drug Courts, Due Process, Felony Disenfranchisement, Incarceration, Policing (2011 Drug War Killings, 2012 Drug War Killings, 2013 Drug War Killings, 2014 Drug War Killings, 2015 Drug War Killings, 2016 Drug War Killings, 2017 Drug War Killings, Arrests, Eradication, Informants, Interdiction, Lowest Priority Policies, Police Corruption, Police Raids, Profiling, Search and Seizure, SWAT/Paramilitarization, Task Forces, Undercover Work), Probation or Parole, Prosecution, Reentry/Rehabilitation, Sentencing (Alternatives to Incarceration, Clemency and Pardon, Crack/Powder Cocaine Disparity, Death Penalty, Decriminalization, Defelonization, Drug Free Zones, Mandatory Minimums, Rockefeller Drug Laws, Sentencing Guidelines)CultureArt, Celebrities, Counter-Culture, Music, Poetry/Literature, Television, TheaterDrug UseParaphernalia, ViolenceIntersecting IssuesCollateral Sanctions (College Aid, Drug Taxes, Housing, Welfare), Violence, Border, Budgets/Taxes/Economics, Business, Civil Rights, Driving, Economics, Education (College Aid), Employment, Environment, Families, Free Speech, Gun Policy, Human Rights, Immigration, Militarization, Money Laundering, Pregnancy, Privacy (Search and Seizure, Drug Testing), Race, Religion, Science, Sports, Women's IssuesMarijuana PolicyGateway Theory, Hemp, Marijuana -- Personal Use, Marijuana Industry, Medical MarijuanaMedicineMedical Marijuana, Science of Drugs, Under-treatment of PainPublic HealthAddiction, Addiction Treatment (Science of Drugs), Drug Education, Drug Prevention, Drug-Related AIDS/HIV or Hepatitis C, Harm Reduction (Methadone & Other Opiate Maintenance, Needle Exchange, Overdose Prevention, Pill Testing, Safe Injection Sites)Source and Transit CountriesAndean Drug War, Coca, Hashish, Mexican Drug War, Opium ProductionSpecific DrugsAlcohol, Ayahuasca, Cocaine (Crack Cocaine), Ecstasy, Heroin, Ibogaine, ketamine, Khat, Kratom, Marijuana (Gateway Theory, Marijuana -- Personal Use, Medical Marijuana, Hashish), Methamphetamine, New Synthetic Drugs (Synthetic Cannabinoids, Synthetic Stimulants), Nicotine, Prescription Opiates (Fentanyl, Oxycontin), Psilocybin / Magic Mushrooms, Psychedelics (LSD, Mescaline, Peyote, Salvia Divinorum)YouthGrade School, Post-Secondary School, Raves, Secondary School